ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India is urging the company to launch its popular weight-loss drug, Wegovy, next year to stay ahead of rival Eli Lilly. Concerns have been raised about Novo potentially lagging behind if Wegovy is not introduced before Lilly's drug,
Announcement as on 03 December 2024

Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India
Novo Nordisk is broadening its Bengaluru operations by increasing senior leadership, doubling global process leaders in India, and boosting headcount by 16% next year. The company is also collaborating with Indian AI startups to improve efficiency, particu
Announcement as on 11 October 2024

Stocks in the news: Novo Nordisk, Lilly, Deere, Levi Strauss, Starbucks and more

Announcement as on 24 September 2024

Novo Nordisk CEO spars with lawmakers over Ozempic, Wegovy prices

Announcement as on 24 September 2024

Novo Nordisk shares drop more than 4% on disappointing obesity pill data
Shares were down 4.3% at 1330 GMT, the lowest since August 8, after the company announced headline results from its trial of monlunabant, an experimental drug it acquired as part of its billion purchase of Canadian biotech company Inversago Pharmaceutic
Announcement as on 20 September 2024

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 36.19
  • 12Day Average: 36.8
  • 20Day Average: 37.56
  • 50Day Average: 44.88
  • 100Day Average: 47.88
  • 150Day Average: 50.45
  • 200Day Average: 53.73

NVO Indicators & signals

Indicator MACD (12,26,9)

36.88, 38.99, -2.49
Indicator MACD is in negative zone

Indicator ADX (14)

23.29, 18.92, 30.41
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
01 Wed Apr 2026 36.48 35.78 to 37.44 -0.73% 1.21 times
31 Tue Mar 2026 36.75 35.32 to 36.75 4.05% 1.2 times
30 Mon Mar 2026 35.32 35.06 to 35.65 -1.97% 0.86 times
27 Fri Mar 2026 36.03 35.89 to 37.20 -0.96% 0.74 times
26 Thu Mar 2026 36.38 35.51 to 37.44 0.14% 1.05 times
25 Wed Mar 2026 36.33 36.23 to 37.39 -1.52% 1.04 times
24 Tue Mar 2026 36.89 36.55 to 37.20 0.19% 1.02 times
23 Mon Mar 2026 36.82 36.48 to 37.21 0.77% 0.95 times
20 Fri Mar 2026 36.54 35.86 to 37.33 -1.43% 1.4 times
19 Thu Mar 2026 37.07 36.17 to 37.47 -3.56% 1.11 times
17 Tue Mar 2026 38.44 38.30 to 39.27 -0.36% 0.64 times
16 Mon Mar 2026 38.58 37.79 to 38.59 1.63% 0.72 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top